Indivior
INDV
0.00
+0.91
+2.57%
Indivior
US · INDV
#2252 by market cap
Listed 1970
0.00
+0.91
+2.57%
Snapshot may be outdated; check the quote time before use.
· 2026-11-02 19:54
Valuation each multiple against its own 5-year range
P/B ratio
-69.63
Cheap vs history
8th percentile
5-year average 0.54
P/E ratio
9.91
In line with history
46th percentile
5-year average 100.91 · forward 8.04 · #4 of 26 in Drug Manufacturers - Specialty & Generic
P/S ratio
3.04
In line with history
65th percentile
5-year average 2.39 · forward 3.04 · #50 of 80 in Drug Manufacturers - Specialty & Generic
Vs. peers Drug Manufacturers - Specialty & Generic
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Indivior (INDV) | 4.28B | 10.16 | -71.42 | 0.00% |
| Takeda Pharmaceutical (TAK) | 69.76B | 311.00 | 1.50 | 1.44% |
| Teva Pharmaceutical Industries (TEVA) | 45.77B | 91.23 | 5.74 | 0.00% |
| Haleon (HLN) | 39.76B | 19.14 | 1.85 | 2.09% |
| Zoetis (ZTS) | 32.14B | 13.34 | 9.73 | 2.64% |
| United Therapeutics (UTHR) | 23.63B | 20.94 | 3.76 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
★★☆☆☆
Fair value29.71
Economic moatNarrow
UncertaintyHigh